"Estrogen Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
Descriptor ID |
D004965
|
MeSH Number(s) |
D06.347.295 D27.505.696.399.450.327
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Estrogen Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Estrogen Antagonists".
This graph shows the total number of publications written about "Estrogen Antagonists" by people in this website by year, and whether "Estrogen Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2010 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estrogen Antagonists" by people in Profiles.
-
Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J Appl Toxicol. 2013 Apr; 33(4):265-72.
-
Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem Res. 2011 Sep; 36(9):1587-93.
-
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro Oncol. 2011 Jan; 13(1):28-41.
-
Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine. Breast Cancer Res Treat. 2010 Jun; 121(2):335-45.
-
Transmission of relaxin and estrogens to suckling canine pups via milk and possible association with hip joint laxity. Am J Vet Res. 2008 Jan; 69(1):59-67.
-
Ductal access for prevention and therapy of mammary tumors. Cancer Res. 2006 Jan 15; 66(2):638-45.
-
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer. 2005 12; 12(4):721-47.
-
Estrogen-sensitive cutaneous polyarteritis nodosa: response to tamoxifen. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 1):643-6.
-
Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen. Cancer Res. 1996 Sep 01; 56(17):4049-55.
-
Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol Reprod. 1993 May; 48(5):1006-13.